(Q41134815)

English

Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: Autoradiographic evidence against the dual mechanism hypothesis

scientific article published on January 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: Autoradiographic evidence against the dual mechanism hypothesis (English)

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

1 reference

based on heuristic

inferred from title

author name string

LaHoste GJ

1

1 reference

Europe PubMed Central

27 September 2017

G. J. LaHoste

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678501

27 October 2022

J. F. Marshall

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678501

27 October 2022

language of work or name

0 references

publication date

1 January 1991

1 reference

Europe PubMed Central

27 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:030645229190342L?httpAccept=text/xml

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

https://api.elsevier.com/content/article/PII:030645229190342L?httpAccept=text/plain

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

1 reference

Europe PubMed Central

27 September 2017

41

1 reference

Europe PubMed Central

27 September 2017

2-3

1 reference

Europe PubMed Central

27 September 2017

473-481

1 reference

Europe PubMed Central

27 September 2017

Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury

1

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography

2

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Computer-assisted video analysis of [3H]spiroperidol binding autoradiographs.

3

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Efferent connections of the substantia nigra and ventral tegmental area in the rat

4

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

5

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

6

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

7

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding

8

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity

9

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum

10

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain

11

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Chronic treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors

12

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs

13

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation

14

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Multiple receptors for dopamine

15

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action

17

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists

18

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.

19

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control

20

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Brain Function: Neural Adaptations and Recovery From Injury

21

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: Quantification using the rotational model

22

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis

23

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors

25

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.

26

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.

27

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

28

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Quantification of dopaminergic supersensitization using apomorphine-induced behavior in the mouse

30

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.

31

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

CNS dopamine autoreceptors: distribution, pharmacology, and function

32

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

33

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.

34

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum

35

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

36

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Dopaminergic A10 neurones are involved in cognitive functions.

39

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive.

40

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotational behavior

41

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.

42

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

43

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism

44

1 reference

10.1016/0306-4522(91)90342-L

https://api.crossref.org/works/10.1016/0306-4522(91)90342-L

27 October 2022

Identifiers

10.1016/0306-4522(91)90342-L

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41134815&oldid=2133066491"